Security key
82711P201
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO)
CUSIP: 82711P201
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Total 13F shares
- 119,574
- Total 13F value
- $117,878
- Share change
- +6,756
- SEC-reported price per share
- $1.00
- Number of holders
- 10
- Value change
- +$5,461
- Number of buys
- 4
- Number of sells
- 4
- Shares outstanding
- 14,275,224
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
10
Top holders
10
SILO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Silo Pharma, Inc. SEC filings
Silo Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 82711P201
Recent filing periods:
Ownership snapshot
Top reported holders of SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Financial Advocates Inves...
Disclosed value leader
Financial Advocates Inves...
Comparable rows
10/10
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.44%
Showing 1-6 of 10 holder rows.
Quick read
Financial Advocates Investment Management leads the comparable SEC ownership view at 0.44%.
10 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Financial Advocates Investment Management's linked filing trail.
Comparable ownership
Top 5
Financial Advocates Investment Ma...
0.44%
VANGUARD GROUP INC
0.11%
GEODE CAPITAL MANAGEMENT, LLC
0.11%
STATE STREET CORP
0.09%
Tower Research Capital LLC (TRC)
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 10 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Financial Advocates Investment Management |
13F
Company
|
0.44%
|
$122,467
62,807 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.11%
|
$31,850
16,334 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.11%
|
$31,063
16,179 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
0.09%
|
$24,000
12,500 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.03%
|
$8,642
4,432 shares
|
— | 31 Mar 2024 |
| UBS Group AG |
13F
Company
|
0%
|
$729
374 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
119,574
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
10
Q2 2024 holders
10
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend